
Yih-horng Shiao
Examiner (ID: 7187, Phone: (571)272-7135 , Office: P/1672 )
| Most Active Art Unit | 1623 |
| Art Unit(s) | 1672, 1623, 1673, 1691, 1621, 1693 |
| Total Applications | 1088 |
| Issued Applications | 699 |
| Pending Applications | 98 |
| Abandoned Applications | 306 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 18737991
[patent_doc_number] => 20230346894
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-11-02
[patent_title] => FORMULATION WITH CANNABINOIDS
[patent_app_type] => utility
[patent_app_number] => 17/970614
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10944
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17970614
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/970614 | FORMULATION WITH CANNABINOIDS | Oct 20, 2022 | Abandoned |
Array
(
[id] => 18307125
[patent_doc_number] => 20230111025
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => METHOD FOR INACTIVATING MOLD SPORES
[patent_app_type] => utility
[patent_app_number] => 18/048579
[patent_app_country] => US
[patent_app_date] => 2022-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4861
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18048579
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/048579 | Method for inactivating mold spores | Oct 20, 2022 | Issued |
Array
(
[id] => 18252381
[patent_doc_number] => 20230079420
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-16
[patent_title] => VITAMIN B12 COMPOUND SUPPLEMENTATION METHODS AND COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 18/046477
[patent_app_country] => US
[patent_app_date] => 2022-10-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22158
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 144
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18046477
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/046477 | VITAMIN B12 COMPOUND SUPPLEMENTATION METHODS AND COMPOSITIONS | Oct 12, 2022 | Abandoned |
Array
(
[id] => 19497688
[patent_doc_number] => 20240336706
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-10
[patent_title] => SILICONE-MODIFIED PULLULAN, A COMPOSITION COMPRISING THE SAME, AND A COSMETIC
[patent_app_type] => utility
[patent_app_number] => 18/700011
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4802
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18700011
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/700011 | SILICONE-MODIFIED PULLULAN, A COMPOSITION COMPRISING THE SAME, AND A COSMETIC | Oct 11, 2022 | Pending |
Array
(
[id] => 19641342
[patent_doc_number] => 20240415862
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => METHODS FOR TREATMENT OF MENOPAUSAL SYNDROMES
[patent_app_type] => utility
[patent_app_number] => 18/703429
[patent_app_country] => US
[patent_app_date] => 2022-10-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11790
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 78
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18703429
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/703429 | METHODS FOR TREATMENT OF MENOPAUSAL SYNDROMES | Oct 11, 2022 | Pending |
Array
(
[id] => 18299976
[patent_doc_number] => 20230109662
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION
[patent_app_type] => utility
[patent_app_number] => 17/957569
[patent_app_country] => US
[patent_app_date] => 2022-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 48795
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17957569
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/957569 | INHIBITORS OF HUMAN IMMUNODEFICIENCY VIRUS REPLICATION | Sep 29, 2022 | Abandoned |
Array
(
[id] => 19613164
[patent_doc_number] => 20240398844
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => PHENYLCOUMARINS FOR TREATING INFLAMMATION
[patent_app_type] => utility
[patent_app_number] => 18/696044
[patent_app_country] => US
[patent_app_date] => 2022-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17696
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18696044
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/696044 | PHENYLCOUMARINS FOR TREATING INFLAMMATION | Sep 28, 2022 | Pending |
Array
(
[id] => 18536137
[patent_doc_number] => 20230241224
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-03
[patent_title] => 2'-ALKYL OR 3'- ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE
[patent_app_type] => utility
[patent_app_number] => 17/950520
[patent_app_country] => US
[patent_app_date] => 2022-09-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37216
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17950520
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/950520 | 2'-ALKYL OR 3'- ALKYL MODIFIED RIBOSE DERIVATIVES AND METHODS OF USE | Sep 21, 2022 | Abandoned |
Array
(
[id] => 19722690
[patent_doc_number] => 20250025441
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-23
[patent_title] => PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/692298
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4857
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692298
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692298 | PHARMACEUTICAL COMPOSITION AND A PROCESS TO PREPARE THE SAME | Sep 20, 2022 | Pending |
Array
(
[id] => 18418502
[patent_doc_number] => 20230172960
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-08
[patent_title] => TOPICAL CAPECITABINE FOR THE TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/934157
[patent_app_country] => US
[patent_app_date] => 2022-09-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 8099
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17934157
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/934157 | TOPICAL CAPECITABINE FOR THE TREATMENT OF HYPERPROLIFERATIVE SKIN CONDITIONS | Sep 20, 2022 | Abandoned |
Array
(
[id] => 19599527
[patent_doc_number] => 20240390407
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => PROMOTER FOR DIFFERENTIATION INTO CARTILAGE CELL, CARTILAGE CELL PROPAGATION PROMOTER, AND CARTILAGE MATRIX PRODUCTION PROMOTER
[patent_app_type] => utility
[patent_app_number] => 18/692618
[patent_app_country] => US
[patent_app_date] => 2022-09-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7312
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 9
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692618
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692618 | PROMOTER FOR DIFFERENTIATION INTO CARTILAGE CELL, CARTILAGE CELL PROPAGATION PROMOTER, AND CARTILAGE MATRIX PRODUCTION PROMOTER | Sep 15, 2022 | Pending |
Array
(
[id] => 19554861
[patent_doc_number] => 20240366653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => COMPOSITION COMPRISING SODIUM HYALURONATE AND AMINO ACIDS FOR USE IN THE ORTHOPEDIC FIELD
[patent_app_type] => utility
[patent_app_number] => 18/691052
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3826
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 120
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691052
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691052 | COMPOSITION COMPRISING SODIUM HYALURONATE AND AMINO ACIDS FOR USE IN THE ORTHOPEDIC FIELD | Sep 14, 2022 | Pending |
Array
(
[id] => 19800489
[patent_doc_number] => 20250066414
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-27
[patent_title] => PROCESSES AND SYSTEMS FOR FLOW-THROUGH OLIGONUCLEOTIDE SYNTHESIS
[patent_app_type] => utility
[patent_app_number] => 18/692033
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10650
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692033
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692033 | PROCESSES AND SYSTEMS FOR FLOW-THROUGH OLIGONUCLEOTIDE SYNTHESIS | Sep 14, 2022 | Pending |
Array
(
[id] => 19768262
[patent_doc_number] => 20250049688
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-13
[patent_title] => COMPOSITION FOR COSMETIC USE
[patent_app_type] => utility
[patent_app_number] => 18/691053
[patent_app_country] => US
[patent_app_date] => 2022-09-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6458
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 121
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18691053
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/691053 | COMPOSITION FOR COSMETIC USE | Sep 14, 2022 | Pending |
Array
(
[id] => 19613283
[patent_doc_number] => 20240398963
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-05
[patent_title] => DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/692340
[patent_app_country] => US
[patent_app_date] => 2022-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46083
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -44
[patent_words_short_claim] => 346
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18692340
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/692340 | DRUG DELIVERY SYSTEM FOR LOCALLY DELIVERING THERAPEUTIC AGENTS AND USES THEREOF | Sep 13, 2022 | Pending |
Array
(
[id] => 19631121
[patent_doc_number] => 20240409570
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-12
[patent_title] => SYNTHETIC COMPOUND, KIT COMPRISING THE SAME, AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 18/690712
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18247
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18690712
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/690712 | SYNTHETIC COMPOUND, KIT COMPRISING THE SAME, AND USES THEREOF | Sep 7, 2022 | Pending |
Array
(
[id] => 18238750
[patent_doc_number] => 20230071061
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-09
[patent_title] => LIQUID AND AGAR FLUOROPHORE PHANTOM
[patent_app_type] => utility
[patent_app_number] => 17/940080
[patent_app_country] => US
[patent_app_date] => 2022-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4735
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 41
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17940080
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/940080 | Liquid and agar fluorophore phantom | Sep 7, 2022 | Issued |
Array
(
[id] => 19503752
[patent_doc_number] => 12115150
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-10-15
[patent_title] => Biomarkers of coronavirus pneumonia
[patent_app_type] => utility
[patent_app_number] => 17/900235
[patent_app_country] => US
[patent_app_date] => 2022-08-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 16141
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 89
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17900235
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/900235 | Biomarkers of coronavirus pneumonia | Aug 30, 2022 | Issued |
Array
(
[id] => 19541699
[patent_doc_number] => 20240358735
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-31
[patent_title] => THERAPEUTIC COMPOSITIONS AND RELATED METHODS
[patent_app_type] => utility
[patent_app_number] => 18/681728
[patent_app_country] => US
[patent_app_date] => 2022-08-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 64597
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -27
[patent_words_short_claim] => 39
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18681728
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/681728 | THERAPEUTIC COMPOSITIONS AND RELATED METHODS | Aug 25, 2022 | Pending |
Array
(
[id] => 18266681
[patent_doc_number] => 20230087923
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-03-23
[patent_title] => PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/821715
[patent_app_country] => US
[patent_app_date] => 2022-08-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32950
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17821715
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/821715 | PARASITICIDAL COMPOSITIONS COMPRISING AN ISOXAZOLINE ACTIVE AGENT, METHODS AND USES THEREOF | Aug 22, 2022 | Abandoned |